Christine Pratilas

32PUBLICATIONS
249CO-AUTHORS
Neurology and neuromuscular diseasesCancer diagnosisPeripheral nervous systemMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 09, 2026
Combination of EZH2 and MEK inhibitors as an effective therapy for neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

|Jun 03, 2026
MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

|May 14, 2026
Imaging features and the role of image-guided biopsy for assessment of premalignant versus malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

|Feb 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.

Patience Odeniyide, Alyza Skaist, Elizabeth Fenner

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Dec 04, 2025
Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Hannah E Price, Stacey Stauffer, Hyun Lee

Pageof 6

Frequent Collaborators

6 joint publications

Angela C Hirbe

5 joint publications

Karisa C Schreck

5 joint publications

Jiawan Wang

5 joint publications

Taylor Sundby